British healthtech company Medopad is offering support to the global healthcare sector by providing clinicians with a specialised Covid-19 version of its remote patient monitoring (RPM) platform. The technology will be available for NHS Trusts across the UK as well as global healthcare providers.

Medopad has worked with Imperial College, Guys’ and St Thomas’ NHS Foundation Trust, as well as Johns Hopkins University to create the specialist Covid-19 RPM platform. It is designed to help monitor ill and at-risk patients, enable care for chronically ill patients and provide insights into the operations of healthcare systems to help them prioritise resources and respond more effectively.

Using Medopad’s RPM app and a clinician dashboard, doctors can track patient data and symptom progression and flag patients with worsening symptoms, both inside and outside of clinical settings. Patients are able to use a corresponding mobile phone app to securely share personal health data such as temperature, respiration rate and heart rate.

Read full story here.